持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/07/05 | 8,650 | 8,660 | 8,530 | 8,650 | -20 | -0.2% | 24,100 |
2016/07/04 | 8,600 | 8,730 | 8,540 | 8,670 | +100 | +1.2% | 32,100 |
2016/07/01 | 8,360 | 8,600 | 8,310 | 8,570 | +320 | +3.9% | 34,300 |
2016/06/30 | 8,330 | 8,330 | 8,180 | 8,250 | -80 | -1% | 39,300 |
2016/06/29 | 8,350 | 8,360 | 8,240 | 8,330 | +100 | +1.2% | 18,300 |
2016/06/28 | 8,030 | 8,370 | 7,990 | 8,230 | +140 | +1.7% | 39,100 |
2016/06/27 | 7,660 | 8,200 | 7,660 | 8,090 | +540 | +7.2% | 43,300 |
2016/06/24 | 8,120 | 8,200 | 7,500 | 7,550 | -570 | -7% | 46,000 |
2016/06/23 | 8,070 | 8,160 | 8,000 | 8,120 | +50 | +0.6% | 22,400 |
2016/06/22 | 8,120 | 8,200 | 7,970 | 8,070 | -50 | -0.6% | 25,800 |
2016/06/21 | 7,900 | 8,170 | 7,850 | 8,120 | +120 | +1.5% | 39,400 |
2016/06/20 | 8,020 | 8,080 | 7,980 | 8,000 | -20 | -0.2% | 32,300 |
2016/06/17 | 8,060 | 8,160 | 8,000 | 8,020 | -10 | -0.1% | 48,900 |
2016/06/16 | 8,230 | 8,310 | 8,020 | 8,030 | -310 | -3.7% | 38,200 |
2016/06/15 | 8,220 | 8,400 | 8,210 | 8,340 | -30 | -0.4% | 31,200 |
2016/06/14 | 8,360 | 8,490 | 8,300 | 8,370 | -110 | -1.3% | 28,700 |
2016/06/13 | 8,590 | 8,670 | 8,480 | 8,480 | -330 | -3.7% | 29,300 |
2016/06/10 | 8,860 | 8,860 | 8,740 | 8,810 | ±0 | ±0% | 36,300 |
2016/06/09 | 8,700 | 8,820 | 8,690 | 8,810 | +10 | +0.1% | 25,500 |
2016/06/08 | 8,680 | 8,800 | 8,610 | 8,800 | +210 | +2.4% | 39,900 |
2016/06/07 | 8,630 | 8,680 | 8,550 | 8,590 | ±0 | ±0% | 21,500 |
2016/06/06 | 8,500 | 8,610 | 8,410 | 8,590 | +50 | +0.6% | 26,000 |
2016/06/03 | 8,440 | 8,620 | 8,440 | 8,540 | +100 | +1.2% | 20,900 |
2016/06/02 | 8,530 | 8,530 | 8,360 | 8,440 | -100 | -1.2% | 33,200 |
2016/06/01 | 8,560 | 8,610 | 8,480 | 8,540 | -100 | -1.2% | 32,800 |
2016/05/31 | 8,500 | 8,640 | 8,350 | 8,640 | +140 | +1.6% | 73,700 |
2016/05/30 | 8,270 | 8,500 | 8,210 | 8,500 | +230 | +2.8% | 39,400 |
2016/05/27 | 8,200 | 8,300 | 8,170 | 8,270 | +20 | +0.2% | 26,000 |
2016/05/26 | 8,190 | 8,290 | 8,020 | 8,250 | +150 | +1.9% | 42,300 |
2016/05/25 | 8,280 | 8,280 | 8,100 | 8,100 | +30 | +0.4% | 26,700 |
2016/05/24 | 7,940 | 8,130 | 7,910 | 8,070 | +150 | +1.9% | 43,900 |
2016/05/23 | 7,850 | 7,950 | 7,840 | 7,920 | +80 | +1% | 27,200 |
2016/05/20 | 7,750 | 7,870 | 7,660 | 7,840 | +90 | +1.2% | 34,600 |
2016/05/19 | 7,710 | 7,780 | 7,680 | 7,750 | +120 | +1.6% | 25,700 |
2016/05/18 | 7,620 | 7,710 | 7,570 | 7,630 | +50 | +0.7% | 39,400 |
2016/05/17 | 7,500 | 7,590 | 7,300 | 7,580 | +200 | +2.7% | 62,700 |
2016/05/16 | 7,750 | 7,820 | 7,320 | 7,380 | -540 | -6.8% | 89,800 |
2016/05/13 | 7,940 | 8,020 | 7,730 | 7,920 | -90 | -1.1% | 67,000 |
2016/05/12 | 8,060 | 8,100 | 7,920 | 8,010 | -140 | -1.7% | 35,200 |
2016/05/11 | 8,300 | 8,300 | 8,050 | 8,150 | ±0 | ±0% | 25,300 |
2016/05/10 | 7,960 | 8,170 | 7,940 | 8,150 | +240 | +3% | 33,500 |
2016/05/09 | 8,010 | 8,040 | 7,880 | 7,910 | -100 | -1.2% | 28,800 |
2016/05/06 | 7,950 | 8,090 | 7,920 | 8,010 | +70 | +0.9% | 29,000 |
2016/05/02 | 7,910 | 7,990 | 7,790 | 7,940 | -220 | -2.7% | 41,500 |
2016/04/28 | 8,230 | 8,350 | 8,080 | 8,160 | -50 | -0.6% | 52,400 |
2016/04/27 | 8,510 | 8,510 | 8,190 | 8,210 | -380 | -4.4% | 66,900 |
2016/04/26 | 8,590 | 8,650 | 8,480 | 8,590 | -10 | -0.1% | 47,800 |
2016/04/25 | 8,560 | 8,690 | 8,560 | 8,600 | -30 | -0.3% | 22,600 |
2016/04/22 | 8,650 | 8,660 | 8,470 | 8,630 | +50 | +0.6% | 40,900 |
2016/04/21 | 8,500 | 8,600 | 8,470 | 8,580 | +190 | +2.3% | 28,000 |
2051~
2100
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム